Xenon Pharmaceuticals Inc. Share Price
XENEXenon Pharmaceuticals Inc. Stock Performance
Open $55.90 | Prev. Close $55.69 | Circuit Range N/A |
Day Range $55.33 - $56.28 | Year Range $28.19 - $63.50 | Volume 70,721 |
Average Traded $55.90 |
Xenon Pharmaceuticals Inc. Share Price Chart
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $55.90 | $56.07 | +0.00% |
30-Apr-26 | $55.90 | $56.07 | +0.58% |
29-Apr-26 | $53.99 | $55.74 | +2.30% |
28-Apr-26 | $54.68 | $54.49 | +0.44% |
27-Apr-26 | $55.77 | $54.25 | -1.77% |
24-Apr-26 | $55.56 | $55.23 | -0.25% |
23-Apr-26 | $57.34 | $55.37 | -2.22% |